Exploring of blood viscosity in injured liver tissues of hyperlipidemic mice
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Computational Drug Discovery Methods · Protein Interaction Studies and Fluorescence Analysis · Metabolomics and Mass Spectrometry Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia10.1152/japplphysiol.01081.2006 ↗
2. Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia10.1194/jlr.M200016-JLR200 ↗
3. Effects of endotoxin and cytokines on lipid metabolism10.1097/00041433-199405030-00008 ↗
4. High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individuals10.1177/2047487319844364 ↗
5. High-density lipoprotein and transport of cholesterol and triglyceride in blood10.1016/j.jacl.2007.02.001 ↗
6. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia10.1194/jlr.M600312-JLR200 ↗
7. Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice10.1016/j.lfs.2014.09.027 ↗
8. Hyperlipidemia and surfactants: the liver sieve is a link10.1016/j.atherosclerosis.2005.12.025 ↗
9. Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors10.1007/s00535-007-2092-2 ↗
10. Safety and efficacy of long-term Co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia10.1016/j.jacc.2005.11.072 ↗
11. Fatty infiltration of liver in hyperlipidemic patients10.1023/A:1005661516165 ↗
12. Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients10.1007/s004670050022 ↗
13. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction10.1097/01.ju.0000125198.32936.38 ↗
14. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia10.1016/j.atherosclerosis.2012.03.011 ↗
15. A luminescent bimetallic iridium(III) complex for ratiometric tracking intracellular viscosity10.1039/C7CC09723A ↗
16. A dynamic model of outer hair cell motility including intracellular and extracellular fluid viscosity10.1121/1.421126 ↗
17. Effect of oxidative stress on receptors and signal transmission10.1016/0009-2797(92)90055-P ↗
18. Crossover behavior in the viscosity of semiflexible polymers: intermolecular interactions as a function of concentration and molecular weight10.1122/1.550777 ↗
19. Viscosity of rice flour: a rheological and biological study10.1021/jf020574i ↗
20. Functionalization of a viscosity-sensitive fluorophore for probing of biological systems10.1016/S0960-894X(98)00241-8 ↗
21. The visualization of mitochondrial viscosity in inflammation, fatty liver, and cancer living mice by a robust fluorescent probe10.1021/acs.analchem.9b01293 ↗
22. NIR fluorescence imaging of lipid drops viscosity in liver organs of diabetic mice10.1016/j.dyepig.2020.109120 ↗
23. Extracellular fluid viscosity enhances liver cancer cell mechanosensing and migration10.1016/j.biomaterials.2018.05.058 ↗
24. Fluorescence imaging of pathophysiological microenvironments10.1039/D1CS00083G ↗
25. Macro-/micro-environment-sensitive chemosensing and biological imaging10.1039/C4CS00051J ↗
26. Recent advances in multifunctional fluorescent probes for viscosity and analytes10.1016/j.ccr.2021.214336 ↗
27. Small molecule based fluorescent chemosensors for imaging the microenvironment within specific cellular regions10.1039/D1CS00645B ↗
28. Tissue-specific near-infrared fluorescence imaging10.1021/acs.accounts.6b00239 ↗
29. Synthesis and bioapplications of Ag2S quantum dots with near-infrared fluorescence10.1002/adma.202007768 ↗
30. One probe for multiple targets: a NIR fluorescent rhodamine-based probe for ONOO− and lysosomal pH detection in live cells10.1016/j.snb.2021.129732 ↗
31. In vivo imaging of Fe2+ using an easily obtained probe with a large Stokes shift and bright strong lipid droplet-targetable near-infrared fluorescence10.1016/j.snb.2020.127796 ↗
32. A general strategy to control viscosity sensitivity of molecular rotor‐based fluorophores10.1002/anie.202011108 ↗
33. Twisted intramolecular charge transfer (TICT) and twists beyond TICT: from mechanisms to rational designs of bright and sensitive fluorophores10.1039/D1CS00239B ↗
34. A viscosity sensitive fluorescent dye for real-time monitoring of mitochondria transport in neurons10.1016/j.bios.2016.07.026 ↗
35. Visualization of ONOO– and viscosity in drug-induced hepatotoxicity with different fluorescence signals by a sensitive fluorescent probe10.1021/acs.analchem.0c03199 ↗
36. A dual-rotator fluorescent probe for analyzing the viscosity of mitochondria and blood10.1039/D1CC00519G ↗
37. A highly sensitive red-emitting probe for the detection of viscosity changes in living cells, zebrafish, and human blood samples10.1039/C9TB02023C ↗
38. Metabolic zonation of the liver: regulation and implications for liver function10.1016/0163-7258(92)90055-5 ↗
39. Assessment of liver metabolic function. Clinical implications10.2165/00003088-199427030-00005 ↗
40. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion10.1080/15548627.2018.1474314 ↗
41. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies10.1016/j.ejphar.2009.06.063 ↗
42. Sesamol treatment reduces plasma cholesterol and triacylglycerol levels in mouse models of acute and chronic hyperlipidemia10.1007/s11745-013-3778-2 ↗
43. Assessment of four experimental models of hyperlipidemia10.1038/laban.710 ↗
44. Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients10.1016/0021-9150(83)90169-7 ↗
45. Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate10.1006/phrs.1996.0046 ↗
46. Fenofibrate:a review of its use in dyslipidaemia10.2165/11208090-000000000-00000 ↗